Fame and future of faecal transplantations – developing next‐generation therapies with synthetic microbiomes
Open Access
- 10 April 2013
- journal article
- review article
- Published by Wiley in Microbial Biotechnology
- Vol. 6 (4), 316-325
- https://doi.org/10.1111/1751-7915.12047
Abstract
While practised for over thousand years, there is presently a renaissance in the interest of using of faecal transplantations to modify the intestinal microbiota of patients. This clinical practice consists of delivering large amounts of bowel microbes in various forms into the intestinal tract of the recipient that usually has been cleared previously. The major reason for the popularity of faecal transplantations is their effectiveness in treating a variety of diseases. Hence, there is a need to develop this procedure to the next level. While there are various developments to select, standardize and store the donor microbiota, it is more challenging to understand the intestinal microbial communities and develop ways to deliver these via robust biotechnological processes. The various approaches that have been followed to do so are discussed in this contribution that is also addressing the concept of the minimal microbiome as well as the production of the synthetic communities that can be instrumental in new therapeutic avenues to modify the intestinal microbiota.Keywords
This publication has 68 references indexed in Scilit:
- Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep SequencingmBio, 2012
- Going viral: next-generation sequencing applied to phage populations in the human gutNature Reviews Microbiology, 2012
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- The human gut virome: Inter-individual variation and dynamic response to dietGenome Research, 2011
- Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic miceProceedings of the National Academy of Sciences of the United States of America, 2011
- Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colonProceedings of the National Academy of Sciences of the United States of America, 2010
- Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficileProceedings of the National Academy of Sciences of the United States of America, 2010
- Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adultsEnvironmental Microbiology, 2009
- The micro-Petri dish, a million-well growth chip for the culture and high-throughput screening of microorganismsProceedings of the National Academy of Sciences of the United States of America, 2007
- Diversity of the human gastrointestinal tract microbiota revisitedEnvironmental Microbiology, 2007